Showing results (341-350 of 403) with videos related to
Sort By:
Pageof 41
The American Journal of Pathology|October 1, 1996
Expression and distribution of amyloid precursor protein-like protein-2 in Alzheimer's disease and in normal brainB J Crain, W Hu, C I Sze, et al.Psychopharmacology|January 1, 1987
Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of MeynertT G Aigner, S J Mitchell, J P Aggleton, et al.Experimental Neurology|May 1, 1991
Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the ratV E Koliatsos, M D Applegate, B Knüsel, et al.Annals of the New York Academy of Sciences|February 24, 2001
The value of transgenic models for the study of neurodegenerative diseasesD L Price, P C Wong, A L Markowska, et al.Neuron|April 16, 1998
An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryosJ A Davis, S Naruse, H Chen, et al.Neurobiology of Aging|February 14, 1998
Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO miceC S von Koch, H Zheng, H Chen, et al.Annals of the New York Academy of Sciences|January 17, 1996
Studies on the metabolism and biological function of APLP2S S Sisodia, G Thinakaran, H H Slunt, et al.Journal of Neurochemistry|January 14, 1999
The copper chaperone CCS is abundant in neurons and astrocytes in human and rodent brainJ D Rothstein, M Dykes-Hoberg, L B Corson, et al.Annals of Neurology|December 1, 1991
Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primatesV E Koliatsos, R E Clatterbuck, H J Nauta, et al.Annals of Neurology|August 1, 1987
Aminergic systems in Alzheimer's disease and Parkinson's diseaseR J D'Amato, R M Zweig, P J Whitehouse, et al.Pageof 41